Skip to main content

The Future of Treatment of RA-ILD: Dr. David Liew

Dr. David Liew reviews abstract OP0124, "Effects of Nintedanib in patients with Progressive Fibrosing Interstitial Lung Disease Associated with Rheumatoid Arthritis (RA-ILD) in the INBUILD Trial", presented at the virtual EULAR 2021 meeting. 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.